The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer's disease -- despite an FDA advisory committee concluding last year that there is not enough evidence to support the effectiveness of the treatment.
원문출처 : https://www.cnn.com/2021/06/07/health/alzheimers-drug-aducanumab-fda-approved-wellness/index.html
원문출처 : https://www.cnn.com/2021/06/07/health/alzheimers-drug-aducanumab-fda-approved-wellness/index.html